CPHI Barcelona has strong showing as bio/pharma industry moves confidently into 2024.
BioPharm International®, Pharmaceutical Technology®, and Pharmaceutical Technology Europe® see a confident bio/pharma industry ready for the new year and looking to merge technology platforms for emerging opportunities.
CPHI Barcelona ran from Oct. 24–26, 2023.
Novartis Acquisition of Regulus Therapeutics is Complete
June 25th 2025A key property included in the acquisition is farabursen, an investigational next-generation oligonucleotide targeting the microRNA miR-17 with preferential kidney exposure, intended to treat people with autosomal dominant polycystic kidney disease.